• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种源自人未分化多形性肉瘤的新细胞系FPS-1的建立与鉴定,该细胞系过表达表皮生长因子受体和环氧化酶-2 。

Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2.

作者信息

Hakozaki Michiyuki, Hojo Hiroshi, Sato Michiko, Tajino Takahiro, Yamada Hitoshi, Kikuchi Shinichi, Abe Masafumi

机构信息

First Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295, Japan.

出版信息

Anticancer Res. 2006 Sep-Oct;26(5A):3393-401.

PMID:17094458
Abstract

BACKGROUND

Undifferentiated pleomorphic sarcoma (UPS) is among the most common soft tissue sarcomas in adults. In order to improve its aggressive course or prognosis and establish new therapeutic methods, molecular genetic and biological characterizations of UPS are required.

MATERIALS AND METHODS

A new human UPS cell line (FPS-1) was established from UPS of the upper arm of a 79-year-old man. The cell line has been maintained for over 14 months with more than 60 passages. FPS-1 cells were characterized using molecular biological methods.

RESULTS

FPS-1 cells showed the same morphological and immunophenotypical characteristics as the primary tumor. Cytogenetic and molecular analyses revealed a nonsense mutation in exon 6 of the p53 gene. Epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) were expressed in FPS-1 cells.

CONCLUSION

FPS-1 cells might be useful for investigating biological behavior and developing new molecular targeting antitumor drugs for UPS with EGFR or COX-2 expression.

摘要

背景

未分化多形性肉瘤(UPS)是成人中最常见的软组织肉瘤之一。为改善其侵袭性病程或预后并建立新的治疗方法,需要对UPS进行分子遗传学和生物学特征分析。

材料与方法

从一名79岁男性上臂的UPS中建立了一种新的人UPS细胞系(FPS-1)。该细胞系已传代60多次,维持培养超过14个月。使用分子生物学方法对FPS-1细胞进行特征分析。

结果

FPS-1细胞表现出与原发肿瘤相同的形态学和免疫表型特征。细胞遗传学和分子分析显示p53基因第6外显子存在无义突变。表皮生长因子受体(EGFR)和环氧合酶-2(COX-2)在FPS-1细胞中表达。

结论

FPS-1细胞可能有助于研究具有EGFR或COX-2表达的UPS的生物学行为,并开发新的分子靶向抗肿瘤药物。

相似文献

1
Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2.一种源自人未分化多形性肉瘤的新细胞系FPS-1的建立与鉴定,该细胞系过表达表皮生长因子受体和环氧化酶-2 。
Anticancer Res. 2006 Sep-Oct;26(5A):3393-401.
2
Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization.一种新的人上皮样肉瘤细胞系FU-EPS-1的建立:应用光谱核型分析和比较基因组杂交技术进行分子细胞遗传学特征分析
Int J Oncol. 2005 Aug;27(2):361-9.
3
Establishment of a new human synovial sarcoma cell line, FU-SY-1, that expresses c-Met receptor and its ligand hepatocyte growth factor.建立一种新的表达c-Met受体及其配体肝细胞生长因子的人滑膜肉瘤细胞系FU-SY-1。
Int J Oncol. 2002 Jul;21(1):17-23.
4
Establishment and characterization of a new cell line, FRTK-1, derived from human malignant rhabdoid tumor of the kidney, with overexpression of epidermal growth factor receptor and cyclooxygenase-2.源自人肾恶性横纹肌样瘤的新细胞系FRTK-1的建立与鉴定,该细胞系表皮生长因子受体和环氧化酶-2过表达。
Oncol Rep. 2006 Aug;16(2):265-71.
5
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?表皮生长因子受体和环氧化酶-2的表达模式及功能相关性:胰腺内分泌肿瘤中的新型化疗靶点?
Am J Gastroenterol. 2009 Jan;104(1):171-81. doi: 10.1038/ajg.2008.33.
6
Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.在雄激素非依赖性前列腺癌中,环氧化酶-2的表达取决于表皮生长因子受体的表达或激活。
Asian J Androl. 2008 Sep;10(5):758-64. doi: 10.1111/j.1745-7262.2008.00423.x.
7
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.中期因子促进软组织肉瘤生长:一个可能的新型治疗靶点。
Clin Cancer Res. 2008 Aug 15;14(16):5033-42. doi: 10.1158/1078-0432.CCR-08-0092.
8
Establishment and characterization of a new human clear-cell sarcoma cell-line, HS-MM.
J Pathol. 1993 Mar;169(3):317-22. doi: 10.1002/path.1711690307.
9
KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate.KIT阴性且表皮生长因子受体基因扩增的未分化子宫内膜肉瘤对甲磺酸伊马替尼呈现暂时反应。
Ann Diagn Pathol. 2007 Feb;11(1):49-54. doi: 10.1016/j.anndiagpath.2006.03.012.
10
Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.表皮生长因子受体及其下游分子在骨与软组织肿瘤中的作用
Hum Pathol. 2007 Jun;38(6):914-25. doi: 10.1016/j.humpath.2006.12.005. Epub 2007 Mar 21.

引用本文的文献

1
Undifferentiated pleomorphic sarcoma invading thoracic aorta treated by thoracic endovascular aortic repair: a case report.经胸主动脉腔内修复术治疗侵犯胸主动脉的未分化多形性肉瘤:一例报告
J Med Case Rep. 2025 Jun 6;19(1):268. doi: 10.1186/s13256-025-05329-5.
2
Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy.新型 PD-L1 和胶原蛋白表达的未分化多形性肉瘤(JBT19)患者来源细胞系作为癌症免疫治疗的模型。
Sci Rep. 2023 Nov 4;13(1):19079. doi: 10.1038/s41598-023-46305-7.
3
Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
未分化多形性肉瘤/肌纤维肉瘤的当前研究与管理
Front Genet. 2023 Feb 16;14:1109491. doi: 10.3389/fgene.2023.1109491. eCollection 2023.
4
In Vitro Human Cancer Models for Biomedical Applications.用于生物医学应用的体外人类癌症模型
Cancers (Basel). 2022 May 3;14(9):2284. doi: 10.3390/cancers14092284.
5
Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.新型人多形性未分化肉瘤TP53缺失细胞系mfh-val2的特性分析
Cytotechnology. 2017 Aug;69(4):539-550. doi: 10.1007/s10616-017-0112-5. Epub 2017 Jul 4.
6
Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.未另行指定的未分化多形性肉瘤的异种移植模型对于治疗药物的临床前测试至关重要。
Oncol Lett. 2016 Aug;12(2):1257-1264. doi: 10.3892/ol.2016.4784. Epub 2016 Jun 24.
7
Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma.热休克蛋白90(HSP90)在未分化多形性肉瘤中的高表达及HSP90抑制剂通过使Akt/mTOR信号通路失活发挥的抗肿瘤作用
BMC Cancer. 2015 Oct 26;15:804. doi: 10.1186/s12885-015-1830-8.
8
Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.环氧化酶-2在恶性外周神经鞘瘤中的过表达及选择性环氧化酶-2抑制剂通过激活半胱天冬酶诱导人恶性外周神经鞘瘤细胞凋亡。
PLoS One. 2014 Feb 6;9(2):e88035. doi: 10.1371/journal.pone.0088035. eCollection 2014.
9
Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.建立一株新型人多形性恶性纤维组织细胞瘤细胞系 FU-MFH-2:多色荧光原位杂交和比较基因组杂交的分子细胞遗传学特征。
J Exp Clin Cancer Res. 2010 Nov 24;29(1):153. doi: 10.1186/1756-9966-29-153.
10
Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2.建立并鉴定一种新型人恶性外周神经鞘瘤细胞系 FMS-1,该细胞系过表达表皮生长因子受体和环氧化酶-2。
Virchows Arch. 2009 Dec;455(6):517-26. doi: 10.1007/s00428-009-0848-1. Epub 2009 Nov 18.